牛牛AI助理已提取核心訊息
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
默沙東公司人類健康國際總裁約瑟夫·羅曼內利於2024年2月13日完成了1,000股公司普通股的出售。該交易在公開市場上進行，股票以每股124.89美元的價格出售，總價值約爲124,888美元。出售後，羅曼內利在默沙東公司的直接持股量爲19,569.325股。此次出售反映了正常交易過程中的交易，是企業高管常規財務活動的一部分。
默沙東公司人類健康國際總裁約瑟夫·羅曼內利於2024年2月13日完成了1,000股公司普通股的出售。該交易在公開市場上進行，股票以每股124.89美元的價格出售，總價值約爲124,888美元。出售後，羅曼內利在默沙東公司的直接持股量爲19,569.325股。此次出售反映了正常交易過程中的交易，是企業高管常規財務活動的一部分。
有用
沒用